griseofulvin and Hair-Diseases

griseofulvin has been researched along with Hair-Diseases* in 6 studies

Reviews

1 review(s) available for griseofulvin and Hair-Diseases

ArticleYear
An approach to the diagnosis and therapy of dermatophytosis.
    International journal of dermatology, 1980, Volume: 19, Issue:10

    Topics: Anti-Inflammatory Agents; Antifungal Agents; Arthrodermataceae; Dermatomycoses; Epidermal Growth Factor; Epidermis; Griseofulvin; Hair; Hair Diseases; Host-Parasite Interactions; Humans; Immunity, Innate; Nail Diseases; Spores, Fungal; Tinea Capitis

1980

Other Studies

5 other study(ies) available for griseofulvin and Hair-Diseases

ArticleYear
Dermoscopic corkscrew hairs dissolve after successful therapy of Trichophyton violaceum tinea capitis: a case report.
    The Australasian journal of dermatology, 2012, Volume: 53, Issue:2

    Topics: Antifungal Agents; Child, Preschool; Dermoscopy; Female; Griseofulvin; Hair Diseases; Humans; Tinea Capitis; Trichophyton

2012
The use of systemic antimycotics in dermatotherapy.
    European journal of dermatology : EJD, 2000, Volume: 10, Issue:2

    Fungal infections of the skin as well as of the nails and hair due to dermatophytes or due to yeasts or moulds still form a major portion of skin diseases overall. Effective therapy of mycoses is not always simple to achieve. In less severe cases topical therapy can be sufficient, but in extensive cutaneous infections, previous resistance to treatment and especially hyperkeratotic tinea and onychomycosis, systemic therapy can be mandatory. For systemic therapy, in particular azoles, i.e. itraconazole and fluconazole as well as the allylamine terbinafine are worth considering. The older antimycotics, i.e. griseofulvin and also ketoconazole are more and more replaced by other, newer drugs. For optimal treatment of a given mycosis, therapy can and should correspond to the individual situation. This applies both to the type of drug and its mode of application. The treatment of choice is the one with the best benefit to risk ratio and the best benefit to cost ratio. Unfortunately, as yet, a cure cannot be expected in every single case.

    Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Dermatomycoses; Fluconazole; Griseofulvin; Hair Diseases; Humans; Itraconazole; Ketoconazole; Naphthalenes; Odds Ratio; Onychomycosis; Terbinafine; Tinea

2000
Cutaneous fungus infections in children.
    Pediatrics in review, 1992, Volume: 13, Issue:4

    Topics: Adolescent; Child; Female; Griseofulvin; Hair Diseases; Humans; Male; Mycoses; Skin Diseases; Sporotrichosis; Tinea

1992
Nonscalp hair infection caused by Microsporum canis in patient with acquired immunodeficiency syndrome.
    Journal of the American Academy of Dermatology, 1991, Volume: 24, Issue:5 Pt 1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Dermatomycoses; Forearm; Griseofulvin; Hair Diseases; Humans; Male; Microsporum

1991
[Current treatment and control of mycotic diseases of the hair bed].
    Medicinski glasnik, 1962, Volume: 16

    Topics: Griseofulvin; Hair; Hair Diseases; Mycoses

1962